AIDS Vaccine 2001 is an international biennial conference created to provide a setting for the presentation of the latest basic, clinical, and public health data relevant to AIDS vaccine development and an opportunity for informal and formal discussions that will facilitate international and interdisciplinary collaborations in the field of AIDS vaccinology. The mission of the conference is to advance research in the field by providing a forum (live and on-line) for the sharing of new information regarding the development, delivery, evaluation, production, and implementation of AIDS vaccines and immunotherapies. The conference will bring together researchers, clinicians, epidemiologists, public health officials, representatives from the pharmaceutical / biotechnology industry, and policy makers from around the world.

Who Should Attend:

• scientists who are conducting basic and
  clinical research in the field of AIDS
  vaccine development
  
• investigators involved in the planning,
  execution, and evaluation of clinical trials
• investigators interested in the testing
  of candidate vaccines in animal models
  
• staff from government agencies and
  policy makers
  
• research and development staff from
  pharmaceutical/biotechnology companies
  
• corporate/licensing personnel from industry
  
• representatives from international public
  health organizations
  
• community activists working in the
  area of vaccines
  
  

  Sponsor:

  -Foundation for AIDS Vaccine Research
  and Development

  Cosponsors:

  -US National Institutes of Health
  -National Institute of Allergy and Infectious Diseases
  -AIDS Vaccine Research Center
  -HIV Vaccine Trials Network
  -Office of AIDS Research
  -National Cancer Institute
  -US Centers for Disease Control and Prevention
  -UNAIDS and the World Health Organization
  -Agence Nationale de Recherches sur le SIDA, France